Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
This study has been completed.
Study NCT00822081   Information provided by Bp Consulting, Inc

First Received on January 12, 2009.   Last Updated on January 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Open-Angle Glaucoma
Ocular Hypertension
Additional conditions recognized in this trial
Glaucoma
Glaucoma, Open-Angle
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Eye Diseases
Vascular Diseases
Additional drug interventions recognized in this trial
Brimonidine
Dorzolamide
Maleic acid
Timolol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Adrenergic Antagonists
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Carbonic Anhydrase Inhibitors
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Bp Consulting, Inc
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services